News
Eli Roth‘s recently-launched company The Horror Section has signed a deal with Construction Film, the German-based production banner founded by producer and actress Veronica Ferres (“The ...
Ivanka Trump Trades Playful Tweets With Eagles Rookie Eli Ricks After He Calls Her ‘Exactly My Type’
Jared Kushner and Ivanka Trump attend the Manus x Machina Fashion in an Age of Technology Costume Institute Gala at the Metropolitan Museum of Art — Photo by ...
According to Pro Football Focus, it is Duke wide receiver Eli Pancol -- an unsurprising pick due to his rare physical traits and clear upside. "Travis Hunter’s arrival completely changes the ...
Eli Lilly (NYSE: LLY) has a strong pipeline of new medicines that could increase the stock price. *Stock prices used were the afternoon prices of May 15, 2025. The video was published on May 17 ...
On May 16, Eli Lilly and Company (NYSE:LLY) announced a partnership with Rznomics to develop RNA-based gene therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion.
Israel has long sought to bring home from Syria the remains of Eli Cohen, whose spying work is credited with helping Israel win the Arab-Israeli War of 1967. By Claire Moses For decades ...
Philadelphia Eagles cornerback Eli Ricks fired off another flirty message to Ivanka Trump, the daughter of President Donald Trump, on Friday following her visit to the Eagles’ facility.
Philadelphia Eagles cornerback Eli Ricks publicly expressed his admiration for Ivanka Trump on X after seeing her in person. Ivanka responded by leaving a note for Ricks at the Eagles' facility ...
HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...
Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on treating hearing loss. The centerpiece of the agreement is ...
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from US rival Eli Lilly, makes inroads into its market share and as its pipeline of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results